Who should be prioritised for COVID-19 vaccines?
Lancet
.
2020 Nov 28;396(10264):1732-1733.
doi: 10.1016/S0140-6736(20)32224-8.
Epub 2020 Oct 27.
Authors
Zaki Hassan-Smith
1
,
Wasim Hanif
2
,
Kamlesh Khunti
3
Affiliations
1
University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2TT, UK. Electronic address:
[email protected]
.
2
University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2TT, UK.
3
Diabetes Research Centre, College of Medicine, Biological Sciences and Psychology, University of Leicester, Leicester, UK.
PMID:
33125934
PMCID:
PMC7832613
DOI:
10.1016/S0140-6736(20)32224-8
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
COVID-19 Vaccines / administration & dosage*
Health Priorities*
Humans
Pandemics
Risk Assessment
Substances
COVID-19 Vaccines